2 active not recruiting, 2 recruiting, 1 terminated. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Active not recruiting 2, Recruiting 2, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Simvastatin 40mg: new trials by email Literature Review of Simvastatin 40mg trials Research Report on Simvastatin 40mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Simvastatin in Alcoholic Liver Fibrosis Simvastatin 40mg - Liver Fibrosis, Alcohol Abuse | Phase 2 / Phase 3 | Recruiting | Anna Cruceta | 90 | 2022-02-22 | 2024-12-04 |
| Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis Placebo Oral Tablet, Simvastatin 40mg - Cirrhosis | Phase 3 | Active not recruiting | VA Office of Research and Development | 142 | 2020-10-02 | 2026-11-19 |
| Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC) Simvastatin 40mg, Placebo oral tablet - Primary Sclerosing Cholangitis | Phase 3 | Active not recruiting | Annika Bergquist | 571 | 2020-10-01 | 2025-09-05 |
| Treatment of Graves´ophthalmopathy with Simvastatin (GO-S) Simvastatin 40mg - Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy | Phase 3 | Recruiting | Lund University | 80 | 2018-01-26 | 2024-09-25 |
| Simvastatin in the Prevention of Recurrent Pancreatitis Simvastatin 40mg, Placebo - Pancreatitis Relapsing | Phase 3 | Terminated | Enrique de-Madaria | 83 | 2017-09-29 | 2025-03-20 |
Alcoholism (1) · Carcinoma, Hepatocellular (1) · Cholangitis, Sclerosing (1) · Fibrosis (1) · Graves Ophthalmopathy (1) · Liver Cirrhosis (1) · Pancreatitis (1) · Pancreatitis, Chronic (1) · Recurrence (1)
Anna Cruceta (1) · Annika Bergquist (1) · Enrique de-Madaria (1) · Lund University (1) · VA Office of Research and Development (1)
Spain (2) · Sweden (2) · United States (1)
Annika Bergquist, MD PhD (1) · David E. Kaplan, MD MSc (1) · Pere Gines, Md (1) · Tereza Planck, MD, PhD (1)
PMID 33644082, PMID 39601354, PMID 40824526, PMID 41482454
2018 (1), I01CX002010 (1)